Oncolytics Biotech (Oncolytics Biotech) Operating Cash Flow per Share : $-0.31 (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Oncolytics Biotech Operating Cash Flow per Share?

Oncolytics Biotech's operating cash flow per share for the three months ended in Dec. 2023 was $-0.06. Oncolytics Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.31.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 14.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Oncolytics Biotech's Operating Cash Flow per Share or its related term are showing as below:

ONCY' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -55.5 Med: 4 Max: 33.3
Current: 8.4

During the past 13 years, Oncolytics Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 33.30% per year. The lowest was -55.50% per year. And the median was 4.00% per year.

ONCY's 3-Year OCF Growth Rate is ranked better than
54.75% of 1242 companies
in the Biotechnology industry
Industry Median: 3.6 vs ONCY: 8.40

Oncolytics Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Oncolytics Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Operating Cash Flow per Share Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.68

-0.43

-0.33

-0.30

-0.31

Oncolytics Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.07	-0.09	-0.10	-0.06	-0.06

Competitive Comparison of Oncolytics Biotech's Operating Cash Flow per Share

For the Biotechnology subindustry, Oncolytics Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncolytics Biotech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oncolytics Biotech's Price-to-Operating-Cash-Flow falls into.

Oncolytics Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Oncolytics Biotech's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-21.205	/	67.624
	=	-0.31

Oncolytics Biotech's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-4.565	/	73.798
	=	-0.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31

Oncolytics Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech (Oncolytics Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (NAS:ONCY) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.